← Oncology Approval Tracker

FDA DECISION ·

Mimrylo

rusfertide · Takeda Pharmaceuticals America

FDA approvalNew therapyPolycythemia vera
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Treatment of erythrocytosis in adults with polycythemia vera.

LAMPGEN ANALYSIS

Why it matters

The hepcidin mimetic gives patients a way to address red-cell overproduction in this myeloproliferative neoplasm. FDA's discussion of VERIFY centers on control of hematocrit and the burden of repeated phlebotomy.

What research teams should watch

Track baseline and follow-up hematocrit, phlebotomy eligibility and actual phlebotomy visits. These measures answer different operational questions about burden.

PRIMARY RECORDS

Sources